Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-30

Clinical Trial Update: Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity [NA]

View source ↗

Summary

This clinical trial update covers a study evaluating whether a 12-week daytime restricted eating regimen improves hepatic steatosis in adults with MASLD. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nantes University Hospital | Conditions: MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) | NA | Status: NOT_YET_RECRUITING